Entasis Therapeutics Hldg: Q1 Earnings Insights

Entasis Therapeutics Hldg ETTX reported its Q1 earnings results on Wednesday, April 27, 2022 at 07:30 AM.

Here's what investors need to know about the announcement.

Earnings

Entasis Therapeutics Hldg missed estimated earnings by 23.08%, reporting an EPS of $-0.32 versus an estimate of $-0.26.

Revenue was down $0.00 from the same period last year.

Past Earnings Performance

Last quarter the company beat on EPS by $0.02 which was followed by a 0.57% increase in the share price the next day.

To track all earnings releases for Entasis Therapeutics Hldg visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.